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ABSTRACT
In recent years, an increase in vaccine hesitancy has led to a decrease in vaccination coverage in several
countries. We conducted a systematic review of studies that assessed knowledge of and attitudes
toward pediatric vaccinations, and the vaccination choices and their determinants among pregnant
women. A total of 6,277 records were retrieved, and 16 full texts were included in the narrative
synthesis. The published literature on the topic shows that, overall, pregnant women believe that
vaccines are important for the protection of their children and the community, but various concerns
and misunderstandings persist around vaccine safety and efficacy, which reduce the trust of expectant
mothers in immunization. Nevertheless, such attitudes and choices vary depending on the vaccine being
considered and the corresponding determinants should therefore be studied in the context of each
specific vaccination. Further research on this topic is needed, particularly in non-western countries.
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Background
Although immunization can be considered one of the greatest
achievements in public health, due to its capacity to reduce
disease, disability, death and inequity worldwide,1 there has
been a marked recent decrease in confidence in vaccination,
particularly in industrialized countries.2 Concerns about vac-
cine safety have led to an increasing number of people seeking
alternative vaccination programs3,4 or deciding to postpone or
even refuse vaccination,5 with a consequent impact on the
maintenance of herd immunity and the spread of infectious
diseases.2,6-8 One of the most direct consequences of the
decrease in vaccination uptake is the upsurge in measles out-
breaks that is currently prevalent in several European coun-
tries, such as Italy9-11 and Romania.9,12 In the USA, over 1,200
individual cases of measles have been confirmed so far in 2019
(to August), accounting for the greatest number of cases
reported there since 1992 and since measles was declared
eliminated in 2000.13
To better understand the factors underlying the decision to
decline current vaccination schedules, the World Health
Organization (WHO) established in 2012, within its Strategic
Advisory Group of Experts (SAGE) on Immunization, a specific
working group (WG) on “Vaccine Hesitancy”,14 which was
defined as: “[a] delay in acceptance or refusal of vaccines despite
availability of vaccine services”. Vaccine hesitancy has been
addressed as “complex and context specific, varying across time,
place and vaccines, influenced by factors such as complacency,
convenience, and confidence”.8 This definition – known as the
“3Cs”model of hesitancy – encompasses the three main drivers of
vaccine acceptance or refusal: complacency and convenience
relate to the perceived risk of disease and the ease with which
vaccine services can be reached (respectively), while vaccine con-
fidence is defined as trust in the effectiveness and safety of vac-
cines and trust in the healthcare system that delivers them.8
Several studies have been conducted to assess the extent
and determinants of hesitancy among different populations
and some of the available evidence has been synthesized in
systematic reviews.15-19 The only published review of studies
addressing hesitancy among expectant mothers has focused
on the acceptance of recommended vaccines during
pregnancy.20 However, pregnant women have been recog-
nized as an ideal target population in which to develop inter-
ventions for the promotion of pediatric vaccinations,
considering that the antenatal period is the time when atti-
tudes and beliefs about childhood vaccines first take shape21
and that pregnancy represents a strategic ‘‘teachable moment”
for health promotion and behavior change.22-24 We therefore
conducted a systematic review to assess the factors affecting
the vaccination choices of pregnant women, searching for
evidence on knowledge, attitudes and childhood immuniza-
tion choices and their determinants, with the aim of support-
ing the development of interventions and promoting further
research in this area.
Methods
This review was conducted according to the Cochrane
Handbook for systematic reviews of interventions.25
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Inclusion criteria
We included primary studies of any type (qualitative or
quantitative, experimental or observational, cross-sectional
or longitudinal) that reported on knowledge of vaccine effi-
cacy and safety, and/or attitudes toward pediatric vaccinations
among pregnant women and/or the intention to vaccinate
their children and/or vaccination uptake after birth. Studies
were also included if they did not aim to assess the association
between knowledge, attitudes and vaccination choices, but
provided descriptive data on at least one of these items.
Cohort studies and experimental studies were included if
they provided baseline data on one of the outcomes of interest
(knowledge of vaccine efficacy and safety, attitudes, intention
to vaccinate). If studies were addressed at parents as the target
population, they were included only if pregnant women were
also included in the sample and if data on this population
could be extracted from the published article or its supple-
mentary material. RCTs aimed at assessing the impact of an
educational intervention were excluded if they did not provide
detailed information on knowledge of vaccine efficacy and
safety or attitudes prior to the intervention; in case of inclu-
sion, only baseline data were extracted for the purpose of the
review. Similarly, in case of studies with a longitudinal design,
only baseline data collected during pregnancy were extracted.
We excluded articles that were not in English.
Search strategy
The literature search was performed on the databases Medline,
Scopus, and Web of Science in May 2019 and updated in
August 2019. Two investigators conducted the literature search
independently, to enhance sensitivity. The search terms used
were: “(Immuniz* OR immunis* OR vaccin*) AND pregnan*
AND (knowledge OR attitude OR trust OR mistrust OR per-
ception OR hesitan* OR accept* OR concern* OR confidence)”.
The strings were adjusted for each database while maintaining
a common overall architecture. The search strategy for Medline
included both MeSH terms and free texts of the primary search
terms. The reference lists of retrieved articles were also searched
to identify potentially relevant studies.
Selection of studies
Studies were selected according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
Statement26 after identifying relevant articles through searches
of electronic databases; duplicates were removed, and titles
and abstracts of the returned citations were screened. Studies
that clearly did not meet the inclusion criteria were excluded.
Full texts of potentially relevant articles were retrieved and
independently examined by two reviewers to determine elig-
ibility. Disagreements were resolved through discussion, and
the reasons for exclusion were recorded.
Data extraction and quality assessment
Data were extracted by two reviewers independently. Data
extraction focused on details of the study population, tools
used for the assessment and main outcomes assessed (knowl-
edge and/or attitudes and/or vaccination choices). Additional
information, such as authors, journal, year of publication, was
also extracted. No data were recorded if they were collected
after an intervention or after birth, except for data on vacci-
nation uptake in children whose mothers’ knowledge of or
attitudes toward vaccination had been assessed during
pregnancy.
Quality was assessed using two tools: the Newcastle-Ottawa
Scale (NOS) adapted for cross-sectional studies27 and the
CASP (Critical Appraisal Skills Programme) Checklist for
qualitative studies.28 The NOS checklist was also used for
RTCs and longitudinal studies, taking only baseline character-
istics into account. Two reviewers assessed the quality of
studies using both checklists independently. Disagreement
was resolved by discussion, resulting in a consensus on the
quality of each study.
Data synthesis
A narrative synthesis of the studies included after eligibility
checks was performed to summarize their key features and to
compare study questions, interventions, methods, and results.
Results
Characteristics of the included articles
We retrieved a total of 6,277 studies. After removal of dupli-
cates and screening of titles and abstracts, 22 full texts
remained, of which 16 were included in the narrative
synthesis29-44 (see Figure 1). The main features of the included
studies are summarized in Table 1. All but one were quantita-
tive studies,30 and three had an experimental design: we
included two randomized controlled trials (RCTs) that assessed
the effectiveness of interventions at improving parental knowl-
edge of and attitudes toward vaccination, with baseline data
collected during pregnancy,33,40 and a pilot study that evalu-
ated the impact of an education course on the attitudes of
pregnant women toward childhood immunization.44 We also
included a cohort study aimed at exploring changes in attitudes
toward vaccination over time, during pregnancy and 3, 6 and
14 months after childbirth.43 Two studies focused on two
specific vaccines, one against HPV30 and one against
rotavirus,31 while all the others assessed childhood vaccinations
in general. All studies were conducted in western nations, with
the exception of one conducted in Japan32 and one in
Malaysia.36
Most quantitative studies made use of an ad hoc question-
naire specifically developed for the purpose of the research
project, although three of them36,37,40 used a version of the
questionnaire developed by Opel et al. for the Parent
Attitudes and Childhood Vaccines (PACV) survey,45,46
which was adapted for pregnant women. The original PACV
survey was self-administered and contained 15 items in three
domains (behavior, safety and efficacy, and general attitudes),
and in the three studies cited it was slightly modified to
include specific items relating to expectant mothers. All
three studies used a cutoff value of 50 in the PACV score
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(range 0 to 100), defining a score >50 as hesitant. Of the other
studies, only three had validated their questionnaire with
a pilot study prior to its use.31,32,43
Most quantitative studies were of moderate quality (see
Table 2), but two were rated low quality.32,44 The qualitative
study by Dubé et al.34 fulfilled the criteria of validity, rele-
vance and quality of the results presented.
Knowledge of vaccine safety and efficacy and its
determinants
Seven studies30-33,41,43,44 aimed to assess how much pregnant
women know about pediatric vaccinations. Weiner et al.,33
Betsch et al.41 and Rosso et al.43 assessed their respondents’
agreement with common vaccination-related messages and mis-
conceptions, including items on vaccine efficacy and safety. The
tools used and the number of items assessed differed across
studies (12, 9 and 8 items respectively). Weiner et al.31 found
that knowledge of vaccines was generally high, with percentages of
agreement over 73% for most items, with two exceptions: about
one third (36%) of expectant mothers did not agree that “A baby’s
immune system can handle several vaccines at one doctor’s visit”,
and about a quarter (23.5%) did not agree that “Scientific studies
and reviews show no relationship between vaccines and autism”.
Conversely, Rosso et al.43 found that knowledge of vaccine safety
and efficacy in their sample of pregnant women was quite low: on
average, women correctly responded to approximately half of the
questions, with 5.5% not responding correctly to any of the state-
ments included in the questionnaire. The authors pointed out that
there was a high level of uncertainty about the proposed state-
ments on vaccine safety and efficacy, with rates of “I don’t know”
responses ranging from 20.3% to 57.7%.43 High rates of uncer-
tainty about common vaccine-related messages were found by
Bechini et al.,44 although they defined those items as “Attitudes of
women towards the most frequent fake news about vaccinations”.
Rosso et al. also investigated factors associated with higher levels
of knowledge,43 finding that being older, having a university
degree, perceiving the quality of the NHS as good or excellent,
and having received information on vaccinations from institu-
tional websites or through education were all associated with
a greater degree of knowledge. On the other hand, factors asso-
ciated with a lower level of knowledge were choosing populist
movements as political orientation, use of alternative medicine
and having received information on vaccines by ‘‘word of
mouth”.43 Saitoh et al. reported low levels of knowledge in their
sample: they assessed basic knowledge about vaccination and self-
reported knowledge of the individual’s understanding of child-
hood vaccination, the first returning a score of 6.7 ± 2.9/13 and
the second of 4.0 ± 3.9/12 in the pre-intervention, and of 5.6 ± 3.2/
13 and 3.6 ± 3.0/12, respectively, in the control group.32
Betsch et al. assessed how the sources of information on
vaccination affected the knowledge of expectant mothers over
Figure 1. PRISMA Flow diagram. Legend: Number of studies identified by search strategy, number of studies excluded and included during primary and secondary
(full -text) screening, and final number of studies included”.
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time; they found that higher knowledge scores were associated
with the use of physicians and television as sources of information,
while midwives and books were associated with lower levels of
knowledge.41 The analysis revealed a significant effect of
a medium level of education, consistent with the findings of
Rosso et al.: women with a maximum of 10 years of school were
less knowledgeable about vaccination than more highly educated
women.43
Morin et al. assessed specific knowledge of gastroenteritis
(GE) and rotavirus infection and vaccination.31 Most mothers
were confident about their knowledge of GE, and correct
response rates to questions on the causes of GE, and its transmis-
sion and prevention, were generally high. However, only 29% of
the sample had already heard about rotavirus vaccination.
Heyman et al. assessed familiarity with HPV infection and
vaccination in their sample of pregnant women, finding prior
knowledge in 79% and 72.3%, respectively, of the sample.30
Five studies assessed the perceived level of knowledge of child-
hood vaccinations in their samples of pregnant women,33,34,42-44
showing that in most cases future mothers were not satisfied with
their familiarity with the topic: the highest rate of positive percep-
tion of their knowledge was found by Danchin et al.,42 where 50%
of mothers strongly agreed that they had enough knowledge to
make a decision about vaccinating their child. In the study by
Weiner et al.,33 42% of women reported being dissatisfied with
their current knowledge level. Rosso et al.43 found that only 30%of
respondents rated their level of knowledge of vaccinations at least
adequate, and in Bechini et al. 41% of women indicated a low level
of knowledge.44 In the qualitative study by Dubé et al.,34 most
vaccine-hesitant mothers said that they lacked sufficient knowl-
edge to make “the right decision”.
Sources of information
The source of information on pediatric vaccination was inves-
tigated in eight studies.30,31,33,36,38,42-44 Only Danchin et al.42
reported healthcare professionals (mainly midwives and GPs)
as the most highly accessed resource, while in all other studies
the internet32,36,42 or media30,31,40,41 were the most frequently
used. Word of mouth was reported as one of the most com-
mon sources of information in all Italian studies,38,43,44 as well
as by Danchin et al.42; the Italian studies also reported fre-
quent use of non-institutional websites by pregnant
women.38,43,44 Studies reporting on the satisfaction of the
information provided by healthcare professionals provided
inconsistent results: Weiner et al. reported that only 15.5%
of the 73 expectant mothers who had received information
from their obstetricianecologistor midwife were very satisfied
with the information,33 while in Rosso et al.43 and Bechini
et al.44 the information provided by healthcare professionals
(including also GPs and pediatricians) was rated as at least
adequate in 78.9% and 71% of cases, respectively. High levels
of satisfaction and trust in healthcare providers were also
reported by Danchin et al. (93–95%).42
Attitudes
Thirteen studies described the attitudes of expectant women
toward childhood vaccination.29,30,32-34,36-44 Three studiesTa
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specifically assessed levels of vaccine hesitancy among expec-
tant mothers through an adapted version of the PAVC
questionnaire.36,39,40 In the study conducted by Mohd Azizi
et al., 25.5% of pregnant women were noted as vaccine-
hesitant, compared to the overall rate of 11.6% for the whole
sample, which also included parents.36 In Daley et al., 14.1%
were classified as vaccine-hesitant at baseline,39 while
Cunningham et al. found lower rates, with 8% of respondents
classified as vaccine-hesitant.38 In a multivariate analysis,
Mohd Azizi et al. found that pregnant mothers expecting
their first child were four times more likely to be vaccine-
hesitant than those who already had one or more children.37
Factors associated with vaccine hesitancy in the study by
Cunningham et al. included holding a college level of educa-
tion or less, compared with holding more than a four-year
degree and not receiving an annual influenza vaccine.38
The importance of vaccination in protecting individuals
and the community against infectious diseases was acknowl-
edged by most pregnant women included in those studies that
assessed this issue.29,32-35,41-44 The three Italian studies also
explored the attitudes of mothers toward the introduction of
compulsory vaccination: both Gualano et al.38 and Bechini
et al.44 found that the majority of women interviewed were in
favor of compulsory vaccination, with rates of 81.6% and 60%,
respectively. In the study by Rosso et al.,43 only 17.8% of
respondents agreed that compulsory vaccination is against
the right of citizens to make choices about their care.
Some studies42,43 reported that not all vaccines against
infectious diseases are perceived as equally important: despite
the high overall level of support for childhood vaccines
recorded in the survey of Danchin et al., these authors also
found that 27% of respondents thought that vaccines are
given to children to prevent diseases that are not common.42
Rosso et al. specifically investigated the perceived benefit of
vaccinating to protect against individual infectious diseases,
finding high rates of uncertainty about the benefit of vaccina-
tion against diphtheria (41.8%), mumps (38.2%) and pertussis
(33.4%), while recording high rates of negative opinion of the
utility of influenza and varicella immunization (64.1% and
33.2 of respondents, respectively).43
The most frequently stated reason against the acceptance of
vaccination in the studies included were the (potential) side
effects of the immunizations.29,30,33,36,43,44 In this regard, sev-
eral studies reported that vaccinations are still seen as
a possible cause of autism.30,42-44 Another frequently reported
concern was the idea that children are getting too many
injections at the same time or too many vaccines during
their first years of life.33,36,42-44 Indeed, some women thought
that developing immunity by getting infections is preferable to
being immunized through vaccinations.29,34,36,44
Other factors that hamper acceptance of pediatric immu-
nization among pregnant women are the frequently reported
negative attitudes toward pharmaceutical companies, seen as
having an economic interest in promoting
vaccination,34,38,43,44 and a lack of trust in the information
provided on vaccination by public authorities and/or health-
care providers.34,38,43 In their qualitative study, Dubé et al.
found that many vaccine-hesitant mothers were looking for
information on vaccination from different sources and many
criticized the lack of “balance” or “neutral” information on
vaccination.34 Gualano et al.38 and Rosso et al.43 found that
35.5% and 45.6% of women, respectively, think that healthcare
professionals do not provide complete information on vacci-
nations, mainly on their side effects.
Corben et al.39 and Danchin et al.42 found that pregnant
women who already had other children were less concerned
about the risks associated with vaccination and were less
hesitant to vaccinate their children than primiparae, while
Heyman et al. found an association between acceptance of
HPV vaccination and educational level, with most women
who accepted this vaccine holding a professional degree.30
Both Rosso et al.43 and Corben et al.39 found an association
between trust in the health system and a positive attitude
toward vaccination. Corben et al. found that respondents
who strongly supported childhood vaccination and were
“not at all hesitant” toward vaccination showed higher levels
of trust in their child’s doctor.39 In a multivariate analysis,
Rosso et al. found a significant association between positive
attitudes and a good perception of the quality of the Country’s
healthcare system.43 Their study also found positive attitudes
to be associated with high levels of knowledge of the safety
and efficacy of vaccines, while having had indirect experience
of the side effects of vaccination and having received informa-
tion about vaccination through the media (TV, radio, news-
papers, etc.) were not likely to result in a positive attitude.43
Of all the attitudinal dimensions assessed in their study,
both at baseline and in the control group, Saitoh et al. found
higher scores relating to perceived severity and social norms
(influencing the decision to vaccinate). Average scores for the
perceived benefits of vaccination were slightly higher than
those for the perceived barriers to vaccination.32
Dubé et al. also found an association between the type of
health professional who delivered information on vaccines
and attitudes toward immunization. In their qualitative
study, all but one of the unfavorable mothers were under
the care of a midwife.34
Finally, Betsch et al. assessed changes in attitudes during
the period from pregnancy to 3, 6 and 14 months after child-
birth, finding that, during all follow-up interviews, the women
had higher risk perceptions and worried more about vaccine-
preventable diseases than about potentially adverse events
associated with vaccination.41
Intention to vaccinate/vaccination uptake and its
determinants
Eleven studies assessed their sample’s intention to
vaccinate29-35,37,40,43,44 and four assessed vaccination uptake
after birth, either based on official registries35,40,41 or on the
responses to follow-up interviews.41
In Wroe et al., 67% of participants stated they would immu-
nize their child, while only 5% stated they definitely would not.
There was a strong association between an individual’s antenatal
ratings of likelihood to immunize and their actual immunization
decision (0.87).29 Seventy-five percent of expectant mothers
included in the study by Weiner et al. planned to have their
child receive all the vaccinations recommended, approximately
15% planned to personalize their vaccination schedule, delaying
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or not receiving some of the recommended vaccines, while 4%
had not yet decided.33 Saitoh et al. found higher rates of women
intending only to accept specific vaccines (50.0%) rather than all
vaccines (33.3%) in their control group, while the proportion of
women intending full immunization was higher in the pre-
intervention group (53%% versus 26.5% of women intending
to accept only some vaccines). Both groups had high rates of
non-respondents.32 Timely immunization was intended by 81%
of women in the study by Grant et al., and this actually occurred
in 70% of the infants surveyed.35 In the study by Corben et al.,
92.2% of women wanted their new baby to receive all the
recommended vaccinations, 83.2% of infants were fully vacci-
nated within 30 days of the recommended date for each vaccine,
and a further 12.1% were immunized after a minor delay (< 10%
of follow-up days). There was a significant association between
intention and actual immunization, with infants of pregnant
women who decided upon full immunization more likely to be
immunized on time (OR = 7.65, 95% CI: 4.87 − 12.18).39
Danchin et al. found “unquestioning acceptors” and “cautious
acceptors” (defined as people willing to accept all vaccines with
no concerns or just minor concerns) accounting for 64.2% and
29.1% of the sample respectively, while refusers of all vaccine
were only 1.2%. In their study, immunization was taken up in
89% of children with available records.42 In their qualitative
study, Dubé et al. found that 35 women out of 54 accepted all
vaccinations, while 12 selected only some of them or chose to
delay immunization.34 Betsch et al. found that 14 months after
birth, on average, children had received 79% of the recom-
mended vaccines.42 In Gualano et al., 98.1% of the sample
intended to vaccinate their children.38
Rosso et al. and Bechini et al. assessed the intention of
pregnant women to vaccinate against specific infectious dis-
eases: in Rosso et al., an intention to vaccinate with the
hexavalent vaccine was expressed by the highest proportion
of respondents (76.8%), followed by the anti-MMR vaccine
(64.3%),43 while Bechini et al. found the highest intention
rates for tetanus (78%), meningitis B and C (74 and 77%,
respectively), pertussis and measles (both 70%).44 At the other
end of the scale, high rates of respondents (26.5% and 11.3%
of women, respectively) indicated that they did not intend to
vaccinate their children with the anti-varicella and the anti-
HPV vaccines in Rosso et al.,43 with 7% of pregnant women
giving the same indication for both varicella and rotavirus
vaccines in Bechini et al.44 Rosso et al. found high levels of
uncertainty about the anti-rotavirus (66.2%) and anti-
pneumococcal vaccines (55.4%).43 In the study by Heyman
et al., intention to vaccinate against HPV depended on the sex
of the fetus, being 27.7% in the case of male and 40.0% for
a female,30 while a study on rotavirus vaccine found the
intention to vaccinate among respondents who had already
heard about this vaccine was 74%.31
Seven studies also conducted an inferential analysis to
assess the determinants of vaccination choices. Factors most
frequently associated with vaccination uptake across studies
were the perceived benefits/value of vaccination for the indi-
vidual and the community29,33,43 and confidence in vaccine
safety.29,33,39,43 Wroe et al. found two main types of factor to
be associated with immunization: perception of risk and ben-
efit of vaccination (immunizers had higher ratings of
perceived personal and community benefit of immunization,
and lower ratings of perceived risk) and emotional factors
(anticipated regret if harm should occur after inaction was
the strongest predictor of likelihood to immunize the child,
along with feelings of responsibility if harm should occur after
inaction and a lower level of regret/feeling of responsibility if
harm should occur after action).29 Betsch et al. assessed atti-
tudes toward vaccination both during pregnancy and after
birth, together with the impact of these attitudes on vaccine
uptake; they found that attitude at 14 months was the only
significant predictor of complete vaccine uptake at 14 months.
A change in attitudes toward vaccination after birth was
found to be associated with changes in concerns about
disease.42
Rosso et al. found that higher levels of knowledge were also
associated with the intention to vaccinate with particular
vaccines (anti-pnemuococcal, anti-meningococcal B and anti-
HPV vaccines).43 The source of information on vaccines also
showed an association with vaccination intentions and uptake:
Rosso et al. found an association between receiving informa-
tion from a health professional and intention to vaccinate
with anti-MMR, anti-meningococcal B and anti-varicella.44
Morin et al. found that having already heard about the rota-
virus vaccine in the media was negatively associated with
uptake of rotavirus vaccination.31 In the qualitative study by
Dubé et al., some differences were observed in decision-
making on vaccination among vaccine-hesitant mothers
under the care of physicians versus midwives, with midwives
strengthening the intention of vaccine-hesitant mothers to
delay vaccination.34
Results on the association between parity and acceptance
of vaccination were inconsistent across studies: while some
found that first-time mothers were more negative about vac-
cinating their children (particularly for some specific vaccines,
as recorded by Mohd Azizi et al. for the rotavirus vaccine,36
and by Rosso et al. for the anti-pneumococcal and anti-
meningococcal C vaccines,43 others found that primiparae
were more likely to intend to vaccinate.31,35 Dubé et al.
found that vaccine-hesitant primipara mothers were more
likely to accept all vaccines than vaccine-hesitant multipara
mothers.30
Both Corben et al.39 and Danchin et al.42 also assessed
maternal immunization (influenza and pertussis vaccines)
during pregnancy as a possible determinant of childhood
vaccination choices, finding no association with children’s
vaccination uptake”.
Socio-demographic factors were not associated with the
intention to vaccinate in most studies, with some exceptions.
Both Grant et al. and Rosso et al. found an association between
lower educational levels and intention to vaccinate (in Rosso
et al., this was statistically significant for the anti-rotavirus
vaccine).35,43 Grant et al. also found an association between
ethnicity and intention to vaccinate, with women of Pacific or
Asian ethnicity being more likely to accept vaccinations.35
Discussion
This systematic review provides a synthesis of the available
evidence on the knowledge of and attitudes toward pediatric
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vaccination, the sources of information most frequently con-
sulted, the frequency of vaccine hesitancy and/or denial, and
factors influencing vaccination choices in pregnant women.
Our literature search showed that pregnant women have
recently been recognized as a key population in which to
study vaccine hesitancy: eight out of the 15 studies included
in this review were published in 2018 and 2019. As expected,
most of the available data on this topic were produced by
research groups based in western countries, where hesitancy
has increased the most, leading to a decrease in vaccination
uptake. However, little evidence has been produced so far at
the European level: one study was conducted in Germany and
three in Italy. More evidence may also be needed from other
European countries, especially from those facing challenges in
maintaining high immunization rates.
All studies found that most women are positive about the
importance of vaccination in protecting individuals and the
community against infectious disease. This is also reflected in
the high rate of women reporting their intention to vaccinate
their children, from a 50.0% intention for specific vaccines
found by Satoh et al.32 to 92.2% reported for childhood vacci-
nation in general reported by Corben et al.39 However, the
studies we surveyed also found high rates of women expressing
concerns about the safety of vaccines and expressing a lack of
trust in the quality and impartiality of information provided by
healthcare professionals. The percentages of hesitant women,
when specifically assessed through the PACV questionnaire,
ranged from 8% reported by Cunningham et al.37 to 25.5% by
Mohd Azizi et al.36 Rates of women declining to vaccinate their
children with all vaccines ranged from 1.2% in Danchin et al.42
to 5% in Wroe et al.29 We found that attitudes relating to the
importance of vaccines and the intention to vaccinate may
depend on the infectious disease in question,36,43,44 suggesting
that the categorization of women as “for” or “against” vaccina-
tion as a whole may not always be appropriate, and that vac-
cine-specific factors, peculiar to each vaccination, need to be
considered among the determinants of acceptance.34,43 This
was also suggested by the WHO SAGE WG, which grouped
the factors influencing the decision to accept, delay or reject
some or all vaccines into three categories: contextual, indivi-
dual and group, and vaccine/vaccination-specific influences.15
The inferential analyses conducted in some of the studies
confirmed that acceptance of pediatric vaccination in this spe-
cific population appears to be mainly driven by issues of com-
placency (perceived benefits of vaccinations) and confidence
(trust in the efficacy and safety of vaccines and in the healthcare
system). As previously suggested,43 an effort should be made to
improve the availability of data on the safety and efficacy of
vaccines, including by non-industry sponsored and unbiased
sources,47,48 and to strengthen reporting and pharmacovigilance
systems.49 Convenience has not found to be a determinant of the
intention to vaccinate nor of vaccination uptake in any of the
studies. Similarly, socio-demographic factors, such as education
or income, do not seem to play a role in influencing hesitancy or
decline of vaccinations in western countries. These data suggest
that vaccine hesitancy is a widespread phenomenon in different
population strata, and that there might be a need to target
messages according to different educational and literacy levels.
In several studies,34,36,40 first-time mothers showed higher levels
of hesitancy and concerns about vaccination than women who
already had children, suggesting they should be a priority target
for interventions aimed at increasing confidence in immuniza-
tion practices. In fact, the first pregnancy represents
a particularly propitious moment, since attitudes and beliefs
about vaccinations are often not yet fully structured.9
Only a few studies assessed how much expectant mothers
know about vaccination, producing inconsistent results.33,44
However, all studies surveyed suggest that misinformation about
the risks associated with vaccines, including the risk of developing
autism and other serious side effects, is still widespread.
Knowledge and awareness issues are among the most frequently
cited reasons for vaccine hesitancy globally and it has been sug-
gested that addressing the gaps in knowledge may help decrease
vaccine hesitancy.50 In this regard, when developing interventions
aimed at increasing vaccine acceptance, an assessment of themost
common knowledge gaps and misbeliefs in the target population
may be useful for tailoring educational messages.
Healthcare professionals were shown to play a secondary role
in informing pregnant women about the risks and benefits of
immunization in nearly all studies, where the media and internet
(also including non-institutional websites) were reported as the
main sources of information on vaccines. This finding suggests
both the need to strengthen the role of healthcare professionals
in discussions around vaccine safety and efficacy and in promot-
ing the positive involvement of various media, while carefully
monitoring the content of the information provided.51 Among
healthcare professionals, midwives would be ideally placed to
support expectant mothers in making informed decisions about
maternal and infant vaccination. However, some of the included
studies also reported pediatricians and GPs as a source of infor-
mation on vaccinations in this population42-44; the importance
of these professionals will becomemore relevant after childbirth,
with the transition from maternity to health and child services,
in a time where decisions about vaccinations take their final
shape. However, the available evidence suggests that while
most healthcare professionals are favorable to vaccinations in
general, there are a wide range of beliefs and concerns in this
group, including doubts regarding the safety and usefulness of
vaccines and mistrust especially of pharmaceutical
companies.19,52-55 Some studies also reported the feeling of not
being sufficiently informed to address parental concerns.19,52
Specific training strategies would be needed to provide different
healthcare providers with the ability to deliver effective commu-
nication regarding vaccines safety and efficacy to parents, but
also with the aim of counteracting hesitant behavior within
health workers themselves.53
This systematic review has some limitations. The first is
strictly linked with the nature of vaccine hesitancy itself,
which, as clearly defined by the SAGE WG, is a context-
specific phenomenon15: the results obtained by the studies in
this survey may therefore not be generalizable to the whole
population of pregnant women. More research would be
needed, mainly in non-western, middle and low income coun-
tries, where different cultural and social factors may play a role
in the acceptance of vaccination.2,56,57 Generalizability is also
limited by the fact that different tools were used across studies
to assess hesitancy, knowledge and attitudes, few of which were
validated prior to their use45,46,58: the same concepts may
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therefore have been measured by different items, making the
results not fully comparable across studies and consequently not
allowing the combination results in a quantitative synthesis. In
this regard, Larson et al. have stressed that many vaccine studies
assess trust in vaccinations mainly through single-item mea-
sures, leaving an implicit definition of trust, indicating that
a thorough understanding of trust as it relates to vaccine accep-
tance is currently under-researched.59
Conclusions
We provide an overview of the available evidence on factors
affecting the vaccination choices of pregnant women in dif-
ferent settings, confirming that pregnancy is a time when
ideas around pediatric immunization begin to take shape.
Therefore, pregnant women represent an ideal target popula-
tion for which strategies aimed at increasing trust in vaccina-
tions could be developed. These strategies should focus on
strengthening the role of healthcare professionals, particularly
midwives, in delivering information on vaccines, increasing
their capacity to effectively manage vaccine hesitancy in par-
ents, but also counteracting hesitant behaviors within health
workers themselves, and on the involvement of different
media tools, which continue to represent the main source of
information for most women. Interventions should be tailored
based on a context-specific analysis of the determinants of
vaccine hesitancy and should also take into account specific
vaccine-related factors. Further evidence from non-western
and low- or middle-income countries may be needed.
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